THERAPY ACCELERATION PROGRAM Trademark

Trademark Overview

On Friday, September 21, 2012, a trademark application was filed for THERAPY ACCELERATION PROGRAM with the United States Patent and Trademark Office. The USPTO has given the THERAPY ACCELERATION PROGRAM trademark a serial number of 76712460. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, November 9, 2023. This trademark is owned by Leukemia & Lymphoma Society, Inc., The. The THERAPY ACCELERATION PROGRAM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

MEDICAL RESEARCH SERVICES IN THE FIELD OF BLOOD RELATED CANCERS
therapy acceleration program

General Information

Serial Number76712460
Word MarkTHERAPY ACCELERATION PROGRAM
Filing DateFriday, September 21, 2012
Status800 - REGISTERED AND RENEWED
Status DateThursday, November 9, 2023
Registration Number4336604
Registration DateTuesday, May 21, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 5, 2013

Trademark Statements

Disclaimer with Predetermined Text"PROGRAM"
Goods and ServicesMEDICAL RESEARCH SERVICES IN THE FIELD OF BLOOD RELATED CANCERS

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, September 25, 2012
Primary Code042
First Use Anywhere DateWednesday, June 7, 2006
First Use In Commerce DateWednesday, June 7, 2006

Trademark Owner History

Party NameLeukemia & Lymphoma Society, Inc., The
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressRye Brook, NY 10573
Party NameLeukemia & Lymphoma Society, Inc., The
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRye Brook, NY 10573
Party NameLeukemia & Lymphoma Society, Inc., The
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRye Brook, NY 10573

Trademark Events

Event DateEvent Description
Thursday, November 9, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, November 9, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, November 9, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, November 9, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, May 16, 2023TEAS SECTION 8 & 9 RECEIVED
Saturday, May 21, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, June 20, 2019NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Thursday, June 20, 2019REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 20, 2019CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, May 13, 2019TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, May 13, 2019TEAS SECTION 8 & 15 RECEIVED
Monday, December 10, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 10, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 21, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, September 6, 2016ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, September 6, 2016TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 18, 2015ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 18, 2015TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, May 21, 2013REGISTERED-PRINCIPAL REGISTER
Tuesday, March 5, 2013PUBLISHED FOR OPPOSITION
Wednesday, February 13, 2013NOTICE OF PUBLICATION
Wednesday, January 30, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, January 30, 2013ASSIGNED TO LIE
Thursday, January 24, 2013EXAMINER'S AMENDMENT MAILED
Thursday, January 24, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, January 24, 2013EXAMINER'S AMENDMENT ENTERED
Thursday, January 24, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, January 21, 2013ASSIGNED TO EXAMINER
Saturday, September 29, 2012APPLICATION FILING RECEIPT MAILED
Tuesday, September 25, 2012NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Related Keywords

program acceleration therapy related cancers blood field research services medical